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ABSTRACT
Harm reduction defines a set of policies and interventions aiming 
to address the adverse health consequences associated with 
drug use. Compared to the general population, prisoners are 
disproportionally affected by HIV. Thanks to its strong emphasis 
on public health and human rights principles, harm reduction can 
effectively reduce transmission of HIV inside prison settings.
INTRODUCTION
• Harm reduction ?
• A set of policies, services, and, interventions aiming to reduce
adverse health consequences associated with drug use and/or
sexual behaviors, whether legal or illegal (Harm Reduction
International, 2020)
• Based on human rights and public health principles
• Examples include testing and counselling, treatment and care,
syringe distribution programs, opioid substitution therapy,..
• Is harm reduction a relevant approach to reduce HIV
transmission inside prisons?
1. Prisoners are disproportionally affected by HIV
CONCLUSIONS
• Global prison population (2018): 10.7 M (Roy Walmsley, 2018)
• Global HIV prevalence (2017): 3.4% (Sayyah et al., 2019)
• From a public health and human rights perspective, harm 
reduction is a relevant approach to address the HIV problem in 
prison settings.
• One major challenge would be the implementation of some harm 
reduction interventions given the high variability  in regulations and 
political will across countries.
References:
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject 
drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3 
• Ferrer-Castro, V., Crespo-Leiro, M. R., García-Marcos, L. S., Pérez-Rivas, M., Alonso-Conde, A., García-Fernández, I., Lorenzo-Guisado, A., Sánchez-Fernández, J. L., Seara-Selas, M., & Sanjosé-Vallejo, R. (2012). [Evaluation of needle exchange program at Pereiro de Aguiar prison (Ourense, Spain): Ten years of experience]. Revista Espanola De 
Sanidad Penitenciaria, 14(1), 3–11. https://doi.org/10.1590/S1575-06202012000100002 
• Harm Reduction International. (2019). Global State of Harm Reduction: 2019 updates. 
• Harm Reduction International. https://www.hri.global/global-state-of-harm-reduction-2019 Harm Reduction International. (2020). What is harm reduction? Harm Reduction International. https://www.hri.global/what-is-harm-reduction 
• Kamarulzaman, A., Reid, S. E., Schwitters, A., Wiessing, L., El-Bassel, N., Dolan, K., Moazen, B., Wirtz, A. L., Verster, A., & Altice, F. L. (2016). Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. The Lancet, 388(10049), 1115–1126. https://doi.org/10.1016/S0140-6736(16)30769-3 
• Sander, G., Shirley-Beavan, S., & Stone, K. (2019). The Global State of Harm Reduction in Prisons. Journal of Correctional Health Care, 25(2), 105–120. https://doi.org/10.1177/1078345819837909 
• Sayyah, M., Rahim, F., Kayedani, G. A., Shirbandi, K., & Saki-Melahi, A. (2019). Global View of HIV Prevalence in Prisons: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health, 48(2), 217–226. 
• United Nations Office on Drugs and Crime. (2015). The United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). 
• Walmsley, Roy. (2018). World prison population list (p. 19). Institute for Criminal Policy Research. https://www.prisonstudies.org/sites/default/files/resources/downloads/wppl_12.pdf 
• World Health Organisation. (2013). WHO | HIV prevention, treatment and care in prisons and other closed settings: WHO; World Health Organization. https://www.who.int/hiv/pub/prisons/interventions_package/en/
2. Prison health is a major concern for public health
• Usually temporary stay with return to community (general population) 
• 60% of people who inject drugs had a history of incarceration globally 
(Degenhardt et al., 2017) 
• OST available in 54 countries (Sander et al., 2019) 
• Syringe distribution in 10/86 countries (Sander et al., 2019)
Figure 3: Relations between 
prison health and public health, 
adapted from (Kamarulzaman et 
al., 2016)
Figure 1 and 2: 
Adapted from 
(Harm 
Reduction 
International, 
2019)
3. Access to health services is a fundamental 
human right
• Principle of equivalence of healthcare (N. Mandela rules)
• Rule 24: “Prisoners should enjoy the same standards of health 
care that are available in the community and should have access 
to necessary health-care services free of charge without 
discrimination on the grounds of their legal status.” (United 
Nations Office on Drugs and Crime, 2015)
• A right mentioned in the international law and conventions and 
recognized by medical ethics regulations (World Health Organisation, 
2013)
• Syringe distribution in Spanish prisons: HIV prevalence decreased to 
8.5% (21% initially) without increasing drug abuse behaviors (Ferrer-
Castro et al., 2012)
